Target intelligence / Profile preview

Basic salivary proline-rich protein 3 (PRB3)

Target
PRB3
Molecular classification
Other (Salivary proline-rich glycoprotein; not a classic receptor, enzyme, channel, or transporter)
01

Overview

Basic salivary proline-rich protein 3 (PRB3) is a human salivary glycoprotein encoded by the PRB3 gene, located on chromosome 12p13 in a cluster with other proline-rich proteins. PRB3 is a major constituent of parotid saliva, notable for its high proline content and substantial inter-individual allelic variation. Its primary biological role is believed to be protection of the oral cavity, particularly through binding dietary polyphenols and facilitating the formation of oral pellicle. PRB3 can act as a bacterial receptor (not a pharmacological receptor), such as for Fusobacterium nucleatum, mediating bacterial adhesion in the mouth. There is some association with head and neck cancers based on gene studies, but PRB3 is not recognized as a direct therapeutic target and there are no known drug interactions or mechanisms of action targeting this molecule. Some evidence links low PRB3 mRNA levels to resistance in prolactinoma therapy, though clinical relevance is uncertain. Overall, PRB3 is best classified as a structural and functional component of saliva rather than a classic drug target.

Other names
Proline rich protein BstNI subfamily 3PRB3PRGParotid salivary glycoprotein G1Proline-rich protein G1G1BstNI type basic salivary proline-rich protein 3G1 parotid salivary glycoproteinPRG, basic salivary proline-rich protein 3
02

Biological functions

Oral cavity defenseDietary polyphenol bindingBacterial adhesionFormation of protective oral environment
03

Disease associations

Head and neck cancer (by association, not as a therapeutic target)Other (limited evidence; possible biomarker in prolactinoma recurrence)
04

Biomarkers

Possibly low PRB3 mRNA as a marker for prolactinoma recurrence and dopamine-agonist resistance (not validated for clinical use)

Beyond the preview

Go deeper on Basic salivary proline-rich protein 3 (PRB3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Basic salivary proline-rich protein 3 (PRB3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call